Grove Bank & Trust Astrazeneca PLC Transaction History

Grove Bank & Trust

$670 Million
Q3 2024

A detailed history of Grove Bank & Trust transactions in Astrazeneca PLC stock. As of the latest transaction made, Grove Bank & Trust holds 11,399 shares of AZN stock, worth $857,432. This represents 0.13% of its overall portfolio holdings.

Number of Shares

11,399

Previous 11,021 3.43%

Holding current value

$857,432

Previous $859,000 3.38%

% of portfolio

0.13%

Previous 0.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$76.67 - $87.62 $28,981 - $33,120	378 Added 3.43%	11,399 $888,000
Q4 2023 Jan 30, 2024	SELL	$61.89 - $69.28 $30,078 - $33,670	-486 Reduced 4.22%	11,021 $742,000
Q3 2023 Oct 30, 2023	BUY	$64.85 - $71.7 $21,984 - $24,306	339 Added 3.04%	11,507 $779,000
Q2 2023 Jul 27, 2023	SELL	$69.91 - $75.81 $6,221 - $6,747	-89 Reduced 0.79%	11,168 $799,000
Q1 2023 May 10, 2023	BUY	$63.15 - $71.6 $3,915 - $4,439	62 Added 0.55%	11,257 $781,000
Q4 2022 Feb 03, 2023	SELL	$54.21 - $70.44 $11,058 - $14,369	-204 Reduced 1.79%	11,195 $759,000
Q3 2022 Oct 28, 2022	SELL	$53.02 - $135.75 $28,100 - $71,947	-530 Reduced 4.44%	11,399 $626,000
Q2 2022 Jul 29, 2022	SELL	$59.26 - $71.14 $829 - $995	-14 Reduced 0.12%	11,929 $788,000
Q3 2021 Oct 28, 2021	BUY	$55.56 - $60.79 $666 - $729	12 Added 0.1%	11,943 $717,000
Q2 2021 Jul 28, 2021	SELL	$48.42 - $60.18 $8,037 - $9,989	-166 Reduced 1.37%	11,931 $714,000
Q1 2021 Apr 23, 2021	SELL	$47.16 - $54.44 $5,470 - $6,315	-116 Reduced 0.95%	12,097 $601,000
Q4 2020 Feb 03, 2021	SELL	$48.52 - $58.02 $97 - $116	-2 Reduced 0.02%	12,213 $610,000
Q2 2020 Jul 31, 2020	SELL	$43.1 - $55.31 $20,386 - $26,161	-473 Reduced 3.73%	12,215 $646,000
Q1 2020 May 05, 2020	SELL	$37.79 - $51.33 $11,261 - $15,296	-298 Reduced 2.29%	12,688 $567,000
Q4 2019 Feb 11, 2020	SELL	$42.46 - $50.46 $44,031 - $52,327	-1,037 Reduced 7.39%	12,986 $647,000
Q3 2019 Oct 30, 2019	SELL	$40.12 - $45.47 $7,903 - $8,957	-197 Reduced 1.39%	14,023 $625,000
Q2 2019 Jul 24, 2019	SELL	$37.28 - $41.68 $116,500 - $130,250	-3,125 Reduced 18.02%	14,220 $587,000
Q1 2019 Apr 26, 2019	SELL	$35.49 - $43.02 $105,618 - $128,027	-2,976 Reduced 14.64%	17,345 $701,000
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $38,776 - $43,647	1,052 Added 5.46%	20,321 $772,000
Q3 2018 Nov 07, 2018	SELL	$34.76 - $39.72 $10,636 - $12,154	-306 Reduced 1.56%	19,269 $763,000
Q2 2018 Aug 03, 2018	BUY	$34.55 - $37.05 $7,497 - $8,039	217 Added 1.12%	19,575 $687,000
Q1 2018 May 07, 2018	BUY	$32.97 - $36.63 $65,049 - $72,270	1,973 Added 11.35%	19,358 $677,000
Q4 2017 Feb 02, 2018	BUY	$32.09 - $34.78 $17,521 - $18,989	546 Added 3.24%	17,385 $603,000
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $487,657 - $572,526	16,839	16,839 $571,000

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account